Breast Neoplasms: all 12,828 studies
Page 74 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- The DIALOGUE Study: Swiss-Korean Billateral CollaborationCompletedNCT04214210Not applicable
- SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast CancerStatus unknownNCT04213898Phase 1/2
- ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based TreatmentsStatus unknownNCT04212702
- Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid TreatmentCompletedNCT04210128
- Immediate Breast Reconstruction With Acellular Dermal MatrixCompletedNCT04209010
- Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based OrganizationCompletedNCT04208724Not applicable
- Exercise Study for Breast Cancer SurvivorsStatus unknownNCT04208074Not applicable
- Effects of Creatine Supplementation in Breast Cancer SurvivorsCompletedNCT04207359Not applicable
- Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast CancerWithdrawnNCT04205786Not applicable
- Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerWithdrawnNCT04205071Phase 1
- Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer SurgeryTerminatedNCT04202640Not applicable
- T-DM1 in HER2-positive Metastatic/Relapsed Breast CancerStatus unknownNCT04202328
- FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.Active, not recruitingNCT04200768Not applicable
- Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsCompletedNCT04200482Phase 2
- Evaluation of Sexual Quality of Life for Breast CancerCompletedNCT04200001
- Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer PatientsWithdrawnNCT04199520Phase 2
- A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast CancerTerminatedNCT04197999Phase 1
- Direct Information to At-risk RelativesActive, not recruitingNCT04197856Not applicable
- TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and SurgeryStatus unknownNCT04197687Phase 2
- Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast CancerStatus unknownNCT04194684Phase 2
- The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY TrialCompletedNCT04193722Phase 3
- Mindfulness and Self-compassion Focussed WalkingStatus unknownNCT04193644Not applicable
- Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast CancerActive, not recruitingNCT04193059Phase 3
- Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast CancerStatus unknownNCT04192903Phase 2
- Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast CancerStatus unknownNCT04192331Phase 2
- E-Based Technology to Provide Decision Aid on Breast Reconstruction for Women With Breast CanceStatus unknownNCT04190992Not applicable
- Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialWithdrawnNCT04190433Phase 2
- A Study to Evaluate the Safety and Clinical Outcome of Using FR-Mask in Breast Cancer Patients With Radiation-irritated Skin After RadiotherapyStatus unknownNCT04190381Not applicable
- Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer PatientsCompletedNCT04190342Not applicable
- A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerActive, not recruitingNCT04188548Phase 1
- A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT04188119Phase 2
- Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-CancerCompletedNCT04187898Phase 1
- The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast CancerStatus unknownNCT04185649Phase 3
- Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedTerminatedNCT04185311Phase 1
- Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast CancerStatus unknownNCT04182568Phase 4
- Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer PatientsActive, not recruitingNCT04180579Not applicable
- the New Geneswell BCT in Vitro Diagnosis of Breast Cancer PrognosisStatus unknownNCT04179318
- Shared Decision Making With Breast Cancer PatientsCompletedNCT04177628Not applicable
- A Study of ZN-c5 in Participants With Breast CancerCompletedNCT04176757Phase 1
- Late-term Effects of Hypofractionated Chest Wall and Regional Nodal Irradiation in Patients With Breast CancerCompletedNCT04175821
- Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast CancerActive, not recruitingNCT04174742
- Lifestyles and Breast CancerActive, not recruitingNCT04174391Not applicable
- Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of LifeCompletedNCT04174248Not applicable
- Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention.CompletedNCT04173897Not applicable
- An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer SurgeryStatus unknownNCT04172350Not applicable
- ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBCActive, not recruitingNCT04172259Phase 2
- Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?CompletedNCT04172220Not applicable
- Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIsCompletedNCT04170920Not applicable
- Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for InjectionStatus unknownNCT04170595Phase 1/2
- Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO)CompletedNCT04170465Phase 2
- Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese PatientsWithdrawnNCT04170335
- An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007TerminatedNCT04168957Phase 1
- Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CTTerminatedNCT04168528Phase 1/2
- Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer PatientsActive, not recruitingNCT04166799Not applicable
- The Recovery of Reaching Movement in Breast Cancer Survivors: Two Different Rehabilitative Protocols in ComparisonCompletedNCT04166279Not applicable
- Protective Role of Vitamin D in Breast Cancer Patients Treated With DoxorubicinCompletedNCT04166253Phase 2
- Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast CancerActive, not recruitingNCT04165993Phase 2
- Effectiveness of Stellate Ganglion Block in Breast Cancer Related LymphedemaStatus unknownNCT04165512Not applicable
- Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for InjectionStatus unknownNCT04164615Phase 3
- Inpatient Screening Mammography for Non-adherent and High Risk WomenCompletedNCT04164251Not applicable
- Progressive Relaxation Training in Breast Cancer Patients Receiving Aromatatase Inhibitor TherapyCompletedNCT04163692Not applicable
- Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa RicaStatus unknownNCT04163159
- Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer SurvivorsWithdrawnNCT04160182Not applicable
- A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 AloneStatus unknownNCT04158947Phase 2
- Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast CancerStatus unknownNCT04158505
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3
- A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin AmericaCompletedNCT04158258
- Acupuncture for Breast Cancer Related LymphedemaStatus unknownNCT04158193Not applicable
- Artificial Intelligence in Mammography-Based Breast Cancer ScreeningWithdrawnNCT04156880
- Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)Status unknownNCT04156841
- Real-time Interactive Digital Healthcare System in Post Operation Patients With Breast Cancer; Pilot StudyCompletedNCT04152590Not applicable
- Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)Active, not recruitingNCT04152499Phase 1/2
- Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast CancerStatus unknownNCT04152057Phase 1/2
- 16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast CancerCompletedNCT04150731Phase 1/2
- Influence of an Intervention on Diet, Physical Exercise and Mindfulness in the Quality of Life of Survivors With Breast CancerCompletedNCT04150484Not applicable
- Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast CancerTerminatedNCT04149522Phase 2
- A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast CancerWithdrawnNCT04149444Phase 2
- Trial Comparing 3 Schedules of Hypofractionated Whole Breast Irradiation in Females With Early Stage Breast CancerCompletedNCT04148586Not applicable
- Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
- Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer PatientsStatus unknownNCT04145947
- Breast Cancer Risk After Diagnostic Gene SequencingCompletedNCT04145817Not applicable
- The Sequelae of Mastectomy and Quadrantectomy Respect to the Reaching Movement in Breast Cancer SurvivorsCompletedNCT04145739Not applicable
- Acupuncture for Insomnia in Breast Cancer Patients Undergoing ChemotherapyCompletedNCT04144309Not applicable
- Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast CancerStatus unknownNCT04143906Phase 2
- Study of DF1001 in Patients With Advanced Solid TumorsCompletedNCT04143711Phase 1/2
- Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant TreatmentCompletedNCT04143282Phase 2
- Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast CancerCompletedNCT04142892Early Phase 1
- Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast CancerWithdrawnNCT04142554Phase 1
- Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast CancerTerminatedNCT04142476Not applicable
- Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BCTerminatedNCT04142060Phase 2
- Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation TherapyStatus unknownNCT04141943Not applicable
- A Multilevel Intervention to Improve Timely Cancer Detection and Treatment InitiationActive, not recruitingNCT04141449Phase 2
- Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
- RBX7455 Before Surgery for the Treatment of Operable Breast CancerTerminatedNCT04139993Phase 1
- Intestinal Microbiota of Breast Cancer Patients Undergoing ChemotherapyStatus unknownNCT04138979
- Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast CancerStatus unknownNCT04138342Phase 1
- Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node DissectionCompletedNCT04137744Not applicable
- Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes MetastasisStatus unknownNCT04137406
- Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast CancerCompletedNCT04134884Phase 1
- ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast CancerActive, not recruitingNCT04134598Phase 3